Home › Utah › Bills
Bills

Utah Congressional Bills

Browse federal bills sponsored by your state's delegation.

Bill results

in committee · Utah · House Sep 30, 2021

HR 5445: GO Ag Act

Growing Opportunities in Agriculture Act or the GO Ag Act This bill directs the Department of Education to award competitive grants to eligible entities (e.g., local educational agencies) to create new agricultural education programs in secondary schools. Agricultural education refers to career and technical education that is focused on agriculture, including classroom or laboratory instruction, work-based learning, and leadership education that is delivered through career and technical student organizations.
Antonio Delgado (D) · 21 co-sponsors
in committee · Utah · House Sep 30, 2021

HR 5443: No Work, No Pay Act of 2021

HR 5443, the "No Work, No Pay Act of 2021," requires that Members of Congress forfeit pay for each day a government shutdown occurs during their pay period. It directly affects sitting Members of Congress (as defined by the Legislative Reorganization Act of 1946) by withholding a daily portion of their salary equal to one day’s pay for every 24-hour period the government is shut down due to a funding lapse. The bill mandates that House payroll administrators (the Chief Administrative Officer for the House or Secretary of the Senate) calculate and exclude this amount from paychecks, with the Treasury Secretary providing necessary support. This provision applies to the 118th Congress and future sessions, effective when a shutdown results from failure to pass appropriations bills or continuing resolutions.
John R. Curtis (R) · 2 co-sponsors
in committee · Utah · House Sep 30, 2021

HR 2748: Israel Relations Normalization Act of 2021

Israel Relations Normalization Act of 2021 This bill requires the Department of State to take certain actions promoting the normalization of relations between Israel, Arab states, and other relevant countries and regions. Specifically, the State Department must develop a strategy on expanding and strengthening the Abraham Accords (the term used to refer collectively to agreements between Israel and the United Arab Emirates and between Israel and Bahrain marking the public normalization of relations between the two Arab countries and Israel). The strategy must include a description of how the U.S. government will encourage further normalization of relations with Israel. In addition, the State Department must report on options for U.S. international efforts to promote the strengthening of ties between Israel, Arab states, and other relevant countries and regions. The State Department must also report on the status of the normalization of relations with Israel, including information on (1) laws that punish individuals for people-to-people relations with Israelis (i.e., anti-normalization laws), and (2) evidence of steps taken by Arab governments toward permitting or encouraging normalized relations between their citizens or residents and Israeli citizens.
Bradley Scott Schneider (D) · 332 co-sponsors
in committee · Utah · Senate Sep 29, 2021

S 2895: Prevent Unconstitutional Vaccine Mandates for Interstate Commerce Act

Prevent Unconstitutional Vaccine Mandates for Interstate Commerce Act This bill prohibits certain departments and agencies from promulgating any rule to require a a person to provide proof of a COVID-19 vaccination in order to engage in interstate commerce or travel. The prohibition applies to The Department of Transportation, Amtrak, The Surface Transportation Board, The Transportation Security Administration, The National Transportation Safety Board, The Federal Maritime Commission, and The Department of Commerce. The bill also limits the authority of the Department of Health and Human Services to mandate vaccination against COVID-19 as a prerequisite for engaging in interstate commerce or travel.
Rick Scott (R) · 4 co-sponsors
in committee · Utah · House Sep 29, 2021

HR 2883: Stop Stalling Access to Affordable Medications

Stop Stalling Access to Affordable Medications This bill makes it an unfair method of competition to submit an objectively baseless petition to the Food and Drug Administration (FDA) in an attempt to interfere with a competitor's application for market approval of a drug. The bill authorizes the Federal Trade Commission to sue an individual or entity that submits such a petition to the FDA. A party found liable in such a lawsuit shall be subject to civil penalties, such as a fine of up to $50,000 for each day that the FDA spent reviewing the baseless petition.
Hakeem S. Jeffries (D) · 8 co-sponsors
in committee · Utah · House Sep 29, 2021

HR 2891: Preserve Access to Affordable Generics and Biosimilars Act

Preserve Access to Affordable Generics and Biosimilars Act This bill authorizes the Federal Trade Commission (FTC) to initiate proceedings against parties to any agreement resolving or settling a patent infringement claim in connection with the sale of a drug or biological product. Such an agreement is presumed to have anticompetitive effects and is a violation of this bill if the filer of the generic drug or biosimilar application receives anything of value and agrees to limit or forego research, development, manufacturing, marketing, or sales of the generic drug or biosimilar. An agreement is exempted if the only consideration granted to the generic manufacturer is (1) the right to market its product prior to the expiration of any statutory exclusivity, (2) a payment for reasonable litigation expenses, or (3) a covenant not to sue on any claim that the generic drug or biosimilar infringes a patent. An agreement is also exempt if the agreement's pro-competitive benefits outweigh the anticompetitive effects. When a generic or biosimilar drug manufacturer enters into an agreement with another drug manufacturer related to the manufacturing, marketing, or sale of a drug, the manufacturers must certify that the material they have given the FTC concerning the agreement contains the complete agreement and any agreements related to that main agreement, including descriptions of any oral agreements or representations. The bill imposes penalties for violations of this bill, including the forfeiture of the 180-day marketing exclusivity period for a generic drug.
Jerrold Nadler (D) · 7 co-sponsors
passed · Utah · House Sep 29, 2021

HR 1693: EQUAL Act of 2021

Eliminating a Quantifiably Unjust Application of the Law Act of 2021 or the EQUAL Act of 2021 This bill eliminates the federal sentencing disparity between drug offenses involving crack cocaine and powder cocaine. Currently, different threshold quantities of crack cocaine and powder cocaine (e.g., 28 grams of crack cocaine and 500 grams of powder cocaine) trigger the same statutory criminal penalties. This bill eliminates the lower quantity thresholds for crack cocaine offenses. Under the bill, the same threshold quantities of crack cocaine and powder cocaine trigger the same statutory criminal penalties. The change applies to future cases and cases pending on the date of enactment. With respect to past cases, the bill authorizes a sentencing court to impose a reduced sentence on a defendant who was convicted or sentenced for a specified crack cocaine offense before this bill's enactment. A defendant does not have to be present at the sentence reduction hearing. Finally, the bill prohibits the reduction of a sentence that was previously reduced.
Hakeem S. Jeffries (D) · 56 co-sponsors
in committee · Utah · Senate Sep 28, 2021

S 2866: TREAT Act

Treatment Restoration for Emergency Antibody Therapeutics Act or the TREAT Act This bill prohibits the Department of Health and Human Services (HHS) from implementing any policy that restricts health care facilities from ordering and receiving COVID-19 monoclonal antibody therapies directly from manufacturers and distributors. In addition, the bill expressly nullifies a policy announced on September 13, 2021, under which HHS allocated supplies of these therapies through state or territorial governments.
Marco Rubio (R) · 8 co-sponsors
in committee · Utah · Senate Sep 27, 2021

S 2861: Opportunities for Fairness in Farming Act of 2021

Opportunities for Fairness in Farming Act of 20 21 This bill establishes restrictions and requirements for checkoff programs, which are programs overseen by the Department of Agriculture (USDA) to promote and provide research and information for a particular agricultural commodity without reference to specific producers or brands. The bill prohibits boards established to carry out a checkoff program or a USDA order issued under a checkoff program from entering into a contract or agreement to carry out program activities with a party that engages in activities to influence any government policy or action that relates to agriculture. A board or its employees or agents acting in their official capacity may not engage in any act that may involve a conflict of interest; anticompetitive activity; unfair or deceptive act or practice; or act that may be disparaging to, or in any way negatively portray, another agricultural commodity or product. Upon approval of USDA, a board may enter directly into contracts and agreements to carry out generic promotion, research, or other activities authorized by law if the agreement or contract requires records accounting for the funds received to be submitted to the board. The board must meet specified requirements regarding the publication of budgets and disbursements of funds. The USDA Inspector General and the Government Accountability Office must conduct specified audits regarding checkoff programs.
Mike Lee (R) · 4 co-sponsors
in committee · Utah · Senate Sep 27, 2021

S 2860: Voluntary Checkoff Program Participation Act

Voluntary Checkoff Program Participation Act This bill prohibits mandatory or compulsory checkoff programs and requires producer participation in the programs to be voluntary at the point of sale. A checkoff program is a program to promote and provide research and information for a particular agricultural commodity without reference to specific producers or brands. The Department of Agriculture oversees the programs, which are requested and funded by industry.
Mike Lee (R) · 1 co-sponsor
Showing 3,013 to 3,024 of 3,540 bills